Disclosures for "Exploring the Impact of Observational Volume Loss and White Matter Changes on Cognitive Function and Mental Health Among Neurologically Healthy Older Adults"
-
Dr. Taylor has nothing to disclose.
-
Jingan Qu has nothing to disclose.
-
-
Miss Lenk has nothing to disclose.
-
Dr. Obusez has nothing to disclose.
-
An immediate family member of Dr. Shah has received personal compensation for serving as an employee of Pfizer. Dr. Shah has stock in Penumbra, Inc.
-
Dr. Poturalski has nothing to disclose.
-
Robyn Busch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Robyn Busch has received research support from NIH.
-
-
Dr. Najm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc. Dr. Najm has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Inc. Dr. Najm has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai Inc.
-
Dr. Machado has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbott. Dr. Machado has received personal compensation in the range of $0-$499 for serving as a Consultant for Enspire. Dr. Machado has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Enspire. Dr. Machado has received stock or an ownership interest from Cardionomics and Ensipire. Dr. Machado has received intellectual property interests from a discovery or technology relating to health care.